SMS 201-995 and Endocrine Tumours
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 21 (sup119) , 251-255
- https://doi.org/10.3109/00365528609087463
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.Gut, 1985
- New somatostatin molecule for management of endocrine tumours.Gut, 1985
- REGRESSION OF METASTATIC VIPOMA WITH SOMATOSTATIN ANALOGUE SMS 201-995The Lancet, 1985
- Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic choleraDigestive Diseases and Sciences, 1982
- PANCREATIC TUMOURS PRODUCE NEUROTENSINJournal of Clinical Endocrinology & Metabolism, 1981
- Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*Journal of Clinical Endocrinology & Metabolism, 1979
- SOMATOSTATIN INHIBITS THE PENTAGASTRIN-INDUCED RELEASE OF SERUM CALCITONIN IN MEDULLARY CARCINOMA OF THE THYROIDClinical Endocrinology, 1978
- Endocrine Pancreatic Islet Disease With DiarrheaArchives of internal medicine (1960), 1974
- VASOACTIVE INTESTINAL PEPTIDE AND WATERY-DIARRHŒA SYNDROMEThe Lancet, 1973
- Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemiaThe American Journal of Medicine, 1958